Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · March 25, 2024

Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution Therapy in Patients With Primary or Recurrent Pterygium

Ophthalmology Science


Additional Info

Ophthalmology Science
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients with Primary or Recurrent Pterygium
Ophthalmol Sci 2024 Mar 04;[EPub Ahead of Print], SM Whitcup, KN Sall, JA Hovanesian, et al

Further Reading